Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hsin Li Tai Pharmaceutical Co., Ltd. is a Taiwan-based pharmaceutical company specializing in the development and manufacturing of generic drug products. Founded in 1976, the company operates a PIC/S GMP-certified facility in Tainan, producing a wide range of dosage forms including tablets, capsules, and oral liquids. Their portfolio covers various therapeutic areas such as cardiovascular, gastrointestinal, and metabolic diseases. Hsin Li Tai provides contract manufacturing services (CMO) alongside its own branded generic products, serving both domestic and international markets. The company is committed to maintaining high quality standards to ensure the safety and efficacy of its medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hsin Li Tai.